A detailed history of Midland Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Midland Wealth Advisors LLC holds 15,373 shares of ABBV stock, worth $2.7 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
15,373
Previous 17,780 13.54%
Holding current value
$2.7 Million
Previous $3.05 Billion 0.45%
% of portfolio
0.18%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$163.84 - $199.33 $394,362 - $479,787
-2,407 Reduced 13.54%
15,373 $3.04 Billion
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $65,166 - $76,099
421 Added 2.43%
17,780 $3.05 Billion
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $95,252 - $108,531
596 Added 3.56%
17,359 $3.16 Billion
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $2.31 Million - $2.6 Million
16,763 New
16,763 $2.6 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Midland Wealth Advisors LLC Portfolio

Follow Midland Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Midland Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Midland Wealth Advisors LLC with notifications on news.